<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02892487</url>
  </required_header>
  <id_info>
    <org_study_id>35RC14_9786_RORC</org_study_id>
    <nct_id>NCT02892487</nct_id>
  </id_info>
  <brief_title>Evaluation of an Active Swallowing Rehabilitation on Quality of Life of Patients Treated by Radiotherapy for Head and Neck Cancer</brief_title>
  <acronym>RORC</acronym>
  <official_title>Evaluation of an Active Swallowing Rehabilitation on Quality of Life of Patients Treated by Radiotherapy for Head and Neck Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Toxicity and mainly dysphagia have increased in head and neck cancers as chemoradiation
      indications have risen over the last decade, leading to a significant loss of quality of life
      for patients. Recently, many retrospective studies and two evidence-based and systematic
      reviews on strategies to reduce radiation-induced dysphagia have suggested a trend toward
      benefit for a preventive swallowing exercise program.

      The main hypothesis of this study is that an early active swallowing therapy can improve the
      Quality of Life (QoL) of patients treated by radiotherapy for head and neck cancer.

      The study will be a randomized controlled, open-label, multicentric phase III clinical trial
      comparing early active swallowing therapy versus non specific swallowing management (usual
      care).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients in both groups will receive dietary and postural advice from the treating physician.
      Patients in the experimental group will be treated with an early active swallowing therapy
      including a consultation with a speech and language therapist twice a week and a detailed
      program of swallowing auto-exercises twice a day, from the start to one month after the end
      of radiotherapy. All speech therapists will be given precise guidelines based on the current
      state of the art and knowledge. All patients will be analyzed in intent-to-treat.

      Two ancillary studies will complete this global concept of the evaluation and prediction of
      severe alteration of Quality of Life (QoL) and Dysphagia.

        1. A first study will evaluate videoradioscopy. Its objectives are to evaluate the ability
           of videoradioscopy at 3 months to predict poor QoL at 6 and 12 months, to identify
           videoradioscopic predictors of severe dysphagia, asymptomatic aspirations,
           cricopharyngeal stenoses and active swallowing rehabilitation efficiency. Each patient
           of both arms of the main study will undergo a videoradioscopy before the beginning of
           the radiation delivery (baseline evaluation), and at 3 and at 12 months. Data analysis
           will be centralized and will concern: APS (Aspiration and Penetration Scale) score,
           residue, Defective Laryngeal elevation, pharyngoesophageal sphincter dysfunction. Data
           will be correlated to the parameters of the main study in order to establish predictive
           models.

        2. A second ancillary study will evaluate the dose-volume histograms of radiotherapy. The
           objectives are to identify predictors of dysphagia and of active swallowing
           rehabilitation efficiency, and to establish &quot;2D&quot; and &quot;3D&quot; predictive models of
           dysphagia. Imaging and dosimetric data (IMRT (Intensity Modified RadioTherapy) planning)
           and dose-volume histogram will be collected from the patients of the main clinical
           trial. Analysis will be centralized. Data will be correlated to the parameters of the
           main study in order to establish predictive models.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 9, 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients experiencing a clinically relevant improvement defined as a decrease of at least 10 points of the score HNSW ( 6 months after radiotherapy compared with the score before radiotherapy</measure>
    <time_frame>6 months after radiotherapy</time_frame>
    <description>HNSW = Head and Neck Swallowing Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EORTC QLQ-C30 score</measure>
    <time_frame>Baseline, 3, 6 and 12 months after radiotherapy</time_frame>
    <description>EORTC QLQ = European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EORTC H&amp;N35 score</measure>
    <time_frame>Baseline, 3, 6 and 12 months after radiotherapy</time_frame>
    <description>EORTC H&amp;N = European Organisation for Research and Treatment of Cancer Head and Neck questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MFI-20 score</measure>
    <time_frame>Baseline, 3, 6 and 12 months after radiotherapy</time_frame>
    <description>MFI = Multidimensional Fatigue Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass index (BMI)</measure>
    <time_frame>Baseline, 3, 6 and 12 months after radiotherapy</time_frame>
    <description>in kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Oral Intake Scale (FOIS)</measure>
    <time_frame>Baseline, 3, 6 and 12 months after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall duration of enteral nutrition</measure>
    <time_frame>12 months after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total treatment duration</measure>
    <time_frame>12 months after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of treatment interruptions</measure>
    <time_frame>12 months after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse events</measure>
    <time_frame>End of radiotherapy (an average of 2 months after baseline), 1, 3, 6 and 12 months after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing specific Quality of Life (SWAL-QOL) score</measure>
    <time_frame>Baseline, 3, 6 and 12 months after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with aspiration and penetration determined by APS (Aspiration and Penetration Scale) scoring</measure>
    <time_frame>Baseline, 3, 6 and 12 months after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of global survival</measure>
    <time_frame>12 months after radiotherapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of survival without recurrence</measure>
    <time_frame>12 months after radiotherapy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">420</enrollment>
  <condition>Cancer of Head and Neck</condition>
  <arm_group>
    <arm_group_label>Early active swallowing therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Swallowing therapy</intervention_name>
    <description>Patients will undergo active swallowing therapy with a speech and language therapist (twice a week) combined to a detailed program of swallowing auto-exercises (twice a day) from start of radiotherapy to one month after the end.</description>
    <arm_group_label>Early active swallowing therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient treated for histologically proven head and neck cancer (oral cavity,
             oropharynx, or hypopharynx cancer) of stages I-IV or larynx cancer of stages II-IV,
             all histologic type, without distant metastasis

          -  Indication of curative radiotherapy alone or associated to chemotherapy or targeted
             therapy, without planned surgery

          -  WHO (World Health Organization) Performance Status 0, 1 or 2

          -  Sufficient cognitive capacities to complete a QoL questionnaire (evaluation by the
             physician at inclusion)

          -  Written informed consent

          -  Patients with health insurance

        Exclusion Criteria:

          -  Previous radiotherapy or surgery of the upper aerodigestive tract

          -  Cancer of paranasal sinuses or nasopharynx or skull base

          -  Medical history of nervous system disease associated to significant sequelae in terms
             of dysphagia

          -  Pregnant or breast-feeding woman

          -  Patient under guardianship, trusteeship or judicial protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franck JEGOUX</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claire LAFOREST</last_name>
    <phone>+33 (0)2 99 28 98 97</phone>
    <email>claire.laforest@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claire FOUGEROU</last_name>
    <phone>+33 (0)2 99 28 37 53</phone>
    <email>claire.fougerou@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Brest University Hospital</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves GOBEL</last_name>
      <email>yves.gobel@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laetitia PLISSON</last_name>
      <email>plisson-l@chu-caen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre François Baclesse</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David BLANCHARD</last_name>
      <email>BLAND@baclesse.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clermont-Ferrand University Hospital</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas SAROUL</last_name>
      <email>nsaroul@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Le Mans Hospital</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric TRUCHOT</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lille University Hospital</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bretagne Sud Hospital</name>
      <address>
        <city>Lorient</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian SIRE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lyon University Hospital</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe CERUSE</last_name>
      <phone>+33 (0)4 26 73 27 70</phone>
      <email>philippe.ceruse@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marseille University Hospital</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas FAKHRY</last_name>
      <phone>+33 (0)4 91 43 55 54</phone>
      <email>nicolas.fakhry@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Alexis Vautrin</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florent ESPITALIER</last_name>
      <phone>+33 2 40 08 34 75</phone>
      <email>florent.espitalier@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Antoine Lacassagne</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tenon Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean LACAU ST GUILY</last_name>
      <phone>+33 (0)1 56 01 62 46</phone>
      <email>jean.lacau@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Poitiers University Hospital</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique La Sagesse</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François BOUILLOUD</last_name>
      <email>fbouilloud@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck JEGOUX</last_name>
      <phone>+33 (0)2 99 28 90 29</phone>
      <email>franck.jegoux@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Strasbourg University Hospital</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe SCHULTZ</last_name>
      <phone>+33 (0)3 88 12 76 52</phone>
      <email>philippe.schultz@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toulouse University Hospital</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie WOISARD</last_name>
      <phone>+33 (0)5 31 15 55 26</phone>
      <email>woisard.v@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tours University Hospital</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvain MORINIERE</last_name>
      <phone>+33 (0)2 47 47 47 28</phone>
      <email>S.MORINIERE@chu-tours.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bretagne Atlantique Hospital</name>
      <address>
        <city>Vannes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Erwan ARZUL</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid BREUSKIN</last_name>
      <phone>+33 (0)1 42 11 46 05</phone>
      <email>Ingrid.BREUSKIN@gustaveroussy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2016</study_first_submitted>
  <study_first_submitted_qc>September 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2016</study_first_posted>
  <last_update_submitted>January 2, 2018</last_update_submitted>
  <last_update_submitted_qc>January 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Quality of life</keyword>
  <keyword>Radiotherapy</keyword>
  <keyword>Dysphagia</keyword>
  <keyword>Oral cavity</keyword>
  <keyword>Oropharynx</keyword>
  <keyword>Hypopharynx</keyword>
  <keyword>Larynx</keyword>
  <keyword>Swallowing rehabilitation</keyword>
  <keyword>Toxicity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

